ASCEND
BY NTHRYS

NTHRYSPhD AssistanceHepatology

Hepatology

Field
Category

Hepatology

Select a category to explore research frontiers

Hepatology200 categories·70 research gap frontiers·30 UIRGs·access £41
UIRG Unique Individual Research GapFrontier Research Gap Frontier, groups 3+ UIRGsChip badge 4 UIRGs in that frontier🔓 One fee unlocks every UIRG under a frontier🧬 Illustrated: graphical abstract published
PathFieldCategoryFrontierUIRGPhD assistance services
Hepatocellular Carcinoma Immunotherapy Resistance
10 frontiers
30
UIRGS
Investigation of immune checkpoint inhibitor resistance mechanisms in HCC and strategies to overcome therapeutic evasion.
RESEARCH GAP FRONTIERS
Exhausted T Cell Resurrection in HCC Microenvironments3Metabolic Reprogramming of Immune Cells in Cirrhotic Livers3Hepatic Stellate Cell-Mediated Immunosuppression in HCC3+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Liver Fibrosis Reversal Molecular Pathways
10 frontiers
10+
UIRGS
Study of molecular mechanisms enabling regression of established hepatic fibrosis and stellate cell deactivation.
RESEARCH GAP FRONTIERS
Hepatic Stellate Cell Dedifferentiation and Matrix DissolutionExtracellular Matrix Remodeling in Advanced Cirrhosis RegressionMicroRNA Networks Orchestrating Fibroblast Apoptosis+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Non-Alcoholic Fatty Liver Disease Lipotoxicity
10 frontiers
10+
UIRGS
Examination of lipid-induced hepatocyte dysfunction and mitochondrial dysfunction in NAFLD pathogenesis.
RESEARCH GAP FRONTIERS
Lipid Droplet Dynamics and Hepatocyte Metabolic FateFree Fatty Acid Signaling in Portal InflammationMitochondrial Lipotoxicity and Oxidative Stress Amplification+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Viral Hepatitis B Cure Strategies
10 frontiers
10+
UIRGS
Development of functional and sterilizing cure approaches targeting integrated HBV DNA and covalently closed circular DNA.
RESEARCH GAP FRONTIERS
Functional Cure Through Sustained Immune ReconstitutioncccDNA Epigenetic Silencing and Histone RemodelingInnate Lymphoid Cells in HBV Viral Control+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Hepatitis C Direct-Acting Antivirals Resistance
10 frontiers
10+
UIRGS
Analysis of treatment-emergent resistance-associated variants and retreatment strategies in HCV infection.
RESEARCH GAP FRONTIERS
Viral Quasispecies Dynamics in DAA-Treated PopulationsNS5A Inhibitor Escape Mechanisms and Structural AdaptationPolymerase Fidelity Loss as Resistance Amplifier+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Liver Transplantation Rejection Biomarkers
10 frontiers
10+
UIRGS
Identification and validation of non-invasive predictive biomarkers for acute and chronic rejection post-transplantation.
RESEARCH GAP FRONTIERS
Circulating MicroRNA Signatures in Allograft ToleranceExtracellular Vesicle Profiling Across Rejection PhenotypesInnate Lymphoid Cells as Early Rejection Sentinels+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Cholestatic Liver Disease Bile Acid Signaling
10 frontiers
10+
UIRGS
Exploration of farnesoid X receptor and TGR5 signaling in primary biliary and primary sclerosing cholangitis.
RESEARCH GAP FRONTIERS
Farnesoid X Receptor Plasticity in Cholestatic ProgressionTGR5-Mediated Immune Tolerance at the Biliary EpitheliumBile Acid Sequestration and Microbial Dysbiosis Feedback Loops+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Hepatic Encephalopathy Neuroinflammation Mechanisms
Investigation of ammonia-independent mechanisms and glial activation in hepatic encephalopathy pathogenesis.
Explore frontiers →
Drug-Induced Liver Injury Predictive Models
Development of machine learning frameworks integrating genetic and metabolic factors for DILI prediction.
Explore frontiers →
Liver Sinusoidal Endothelial Cell Dysfunction
Study of capillarization and loss of fenestrations in liver sinusoidal endothelial cells during cirrhosis.
Explore frontiers →
Hepatic Stellate Cell Transdifferentiation Regulation
Characterization of epigenetic and transcriptional control of myofibroblast activation in stellate cells.
Explore frontiers →
Cholangiocarcinoma Targeted Molecular Therapies
Development of precision therapeutics targeting FGFR, IDH1, and KRAS mutations in intrahepatic cholangiocarcinoma.
Explore frontiers →
Liver-Derived Extracellular Vesicles Biomarkers
Utilization of hepatocyte and stellate cell-derived exosomes as diagnostic and prognostic biomarkers.
Explore frontiers →
Alcohol-Related Liver Disease Gut Microbiota
Analysis of dysbiosis-driven lipopolysaccharide translocation and innate immune activation in ALD.
Explore frontiers →
Metabolic Dysfunction-Associated Fatty Liver Disease
Investigation of insulin resistance and metabolic syndrome contributions to MAFLD pathogenesis.
Explore frontiers →
Autoimmune Hepatitis HLA Genetics Susceptibility
Examination of HLA allele associations and CD4+ T cell epitope recognition in autoimmune hepatitis.
Explore frontiers →
Liver Regeneration Growth Factor Signaling
Study of hepatocyte proliferation regulation following partial hepatectomy and transplantation.
Explore frontiers →
Hepatic Macrophage Polarization and Inflammation
Investigation of Kupffer cell M1/M2 polarization dynamics in chronic liver disease progression.
Explore frontiers →
Portal Hypertension Angiogenesis Dysregulation
Study of abnormal vasculogenesis and endothelial dysfunction contributing to portal pressure elevation.
Explore frontiers →
Hepatocellular Carcinoma Tumor Microenvironment
Characterization of cancer-associated fibroblasts and immune cell infiltration in HCC progression.
Explore frontiers →
Cholestasis-Induced Oxidative Stress Hepatotoxicity
Analysis of reactive oxygen species generation and mitochondrial dysfunction in cholestatic liver injury.
Explore frontiers →
Hepatitis Delta Virus Replication and Pathogenesis
Investigation of HDV assembly, prenylation requirements, and coinfection dynamics with HBV.
Explore frontiers →
Liver Gene Therapy Vector Development
Engineering of hepatotropic viral and non-viral vectors for chronic liver disease genetic correction.
Explore frontiers →
Hepatic Progenitor Cell Differentiation Plasticity
Study of bipotent hepatic stem cell commitment toward hepatocyte versus cholangiocyte lineages.
Explore frontiers →
Cirrhosis-Associated Immune Dysfunction Mechanism
Examination of bacterial translocation-driven immune activation and immune tolerance in advanced cirrhosis.
Explore frontiers →
Organoid-Based Liver Disease Modeling
Development of three-dimensional tissue engineered models for fibrosis, HCC, and regeneration studies.
Explore frontiers →
Metabolic-Associated Fatty Liver Disease Heterogeneity
Phenotypic and molecular characterization of metabolically dysfunctional versus protected obese patients.
Explore frontiers →
Hepatic Metabolism Circadian Rhythm Regulation
Investigation of clock gene-driven control of lipid, glucose, and protein synthesis in hepatocytes.
Explore frontiers →
Cholestatic Pruritus Neural Sensory Mechanisms
Study of lysophosphatidic acid and autotaxin-driven itch signaling in cholestatic liver disease.
Explore frontiers →
Varices Rupture Hemostasis and Rebleeding
Analysis of endothelial dysfunction and impaired coagulation contributing to variceal hemorrhage risk.
Explore frontiers →
Viral Hepatitis E Chronic Infection Immunology
Investigation of HEV persistence mechanisms in immunocompromised hosts and viral escape variants.
Explore frontiers →
Liver-Specific Antigen Presentation Tolerance
Study of hepatic tolerogenic dendritic cells and regulatory T cell induction mechanisms.
Explore frontiers →
Fibrosis-Associated Hepatocellular Carcinoma Risk
Identification of molecular drivers of malignant transformation in cirrhotic versus non-cirrhotic livers.
Explore frontiers →
Intrahepatic Cholestasis Pregnancy Pathophysiology
Investigation of estrogen-mediated bile salt transporter dysfunction and fetal complications.
Explore frontiers →
Hepatocellular Carcinoma Metabolic Reprogramming
Study of Warburg effect, glutaminolysis, and lipid metabolism alterations in HCC development.
Explore frontiers →
Liver Fibrosis Staging Noninvasive Biomarkers
Development and validation of serum and imaging-based surrogate markers for fibrosis quantification.
Explore frontiers →
Hepatitis A Immune Memory and Vaccination
Investigation of long-lived antibody responses and T cell memory durability post-HAV vaccination.
Explore frontiers →
Bile Acid-Mediated Metabolic Signaling Therapy
Development of farnesoid X receptor and TGR5 agonists for metabolic and fibrotic liver disease.
Explore frontiers →
Drug Metabolism Polymorphisms Hepatotoxicity Prediction
Pharmacogenomic profiling of cytochrome P450 variants and DILI susceptibility risk stratification.
Explore frontiers →
Stellate Cell Senescence and Fibrosis Progression
Study of senescence-associated secretory phenotype in activated stellate cells driving fibrosis.
Explore frontiers →
Primary Sclerosing Cholangitis Genetic Susceptibility
Investigation of GWAS-identified risk loci and rare variants in PSC pathogenesis.
Explore frontiers →
Hepatic Steatosis Lipid Droplet Dynamics
Characterization of adipose triglyceride lipase, atg proteins, and selective autophagy in hepatosteatosis.
Explore frontiers →
Spontaneous Bacterial Peritonitis Prevention Strategies
Development of targeted probiotics and immunomodulatory approaches to reduce SBP incidence.
Explore frontiers →
Hepatic Mitochondrial Dysfunction and Apoptosis
Investigation of oxidative phosphorylation impairment and intrinsic apoptotic pathway activation.
Explore frontiers →
Combination Immunotherapy for Advanced HCC
Evaluation of synergistic checkpoint inhibitor combinations and integration with targeted therapies.
Explore frontiers →
Liver-Associated Neuropsychiatric Complications
Study of minimal hepatic encephalopathy and cognitive decline mechanisms independent of ammonia.
Explore frontiers →
Hepatitis B Surface Antigen Escape Mutants
Characterization of vaccine and antibody-resistant HBsAg variants and their clinical implications.
Explore frontiers →
Metabolic Liver Disease Dietary Intervention
Investigation of specific macronutrient and micronutrient combinations for NAFLD/MAFLD reversal.
Explore frontiers →
Hepatocyte Dedifferentiation and Stemness Markers
Study of reprogramming factors and surface markers identifying hepatic stem-like cell populations.
Explore frontiers →
Cholangitis Bacterial Infection Mechanisms
Investigation of ascending cholangitis pathogenesis and biofilm formation in biliary strictures.
Explore frontiers →
Hepatic Lipophagy Autophagy Regulation
Investigation of selective autophagy mechanisms controlling hepatic lipid degradation and their therapeutic targeting in fatty liver diseases.
Explore frontiers →
Liver-Gut Barrier Dysfunction Endotoxemia
Characterization of intestinal permeability changes and lipopolysaccharide translocation pathways in advanced liver disease progression.
Explore frontiers →
Hepatic Oxidative Stress Antioxidant Defense
Analysis of reactive oxygen species generation and endogenous antioxidant system failures in chronic hepatic pathologies.
Explore frontiers →
Hepatocellular Carcinoma Stemness and Plasticity
Examination of cancer stem cell properties and epithelial-mesenchymal transition dynamics in primary liver cancers.
Explore frontiers →
Liver Fibrosis Collagen Cross-Linking
Investigation of post-translational collagen modifications and enzymatic cross-linking mechanisms driving irreversible fibrotic remodeling.
Explore frontiers →
Hepatic Ischemia-Reperfusion Injury Mechanisms
Study of cellular and molecular events during liver transplantation-related hypoxia-reoxygenation injury and protective strategies.
Explore frontiers →
Viral Hepatitis Innate Immune Response
Analysis of interferon signaling pathways, pattern recognition receptors, and innate lymphoid cell responses in viral hepatitis.
Explore frontiers →
Hepatic Lipid Metabolism Transcriptional Control
Examination of nuclear receptors and transcription factor networks regulating hepatic fatty acid synthesis and oxidation.
Explore frontiers →
Cholangiocarcinoma Tumor-Infiltrating Lymphocytes
Investigation of T-cell and B-cell populations within bile duct cancers and their prognostic significance.
Explore frontiers →
Liver Regeneration Metabolic Reprogramming
Study of acute metabolic shifts during hepatic resection recovery including glucose metabolism and amino acid utilization.
Explore frontiers →
Hepatic Copper Accumulation Mechanisms
Research on copper transporters, sequestration pathways, and toxicity in cholestatic liver diseases.
Explore frontiers →
Primary Biliary Cholangitis Autoimmune Pathogenesis
Investigation of anti-mitochondrial antibody production, T-cell tolerance breakdown, and genetic-environmental triggers in PBC.
Explore frontiers →
Hepatocyte Senescence and Aging
Characterization of age-related cellular senescence in hepatocytes and senescence-associated inflammatory mediators.
Explore frontiers →
Liver Tissue Engineering Biomaterial Scaffolds
Development of decellularized matrices and synthetic polymers for three-dimensional hepatocyte cultivation and function.
Explore frontiers →
Hepatitis B Pregenomic RNA Processing
Analysis of viral RNA packaging, reverse transcription, and covalently closed circular DNA formation mechanisms.
Explore frontiers →
Hepatic Inflammation MicroRNA Regulation
Study of microRNA dysregulation in inflammatory signaling pathways controlling hepatic immune cell activation.
Explore frontiers →
Liver Cancer Genomic Heterogeneity Subtypes
Multi-omics analysis identifying distinct molecular subtypes of hepatocellular carcinoma with prognostic and therapeutic implications.
Explore frontiers →
Hepatic Glucose Production Regulation
Investigation of gluconeogenic enzyme expression and glycogenolysis control in maintaining blood glucose homeostasis.
Explore frontiers →
Cholestatic Liver Disease Ductular Reaction
Examination of reactive cholangiocyte proliferation, progenitor cell mobilization, and inflammatory signals in obstructive disease.
Explore frontiers →
Hepatocellular Carcinoma Angiogenesis Inhibition
Research on vascular endothelial growth factor signaling blockade and alternative neovascularization pathways in HCC.
Explore frontiers →
Liver Fibrosis Cellular Senescence Clearance
Investigation of senolytic therapy approaches targeting senescent hepatic stellate cells to reverse established fibrosis.
Explore frontiers →
Hepatic Protein Synthesis Circulating Albumin
Study of albumin production regulation, secretion pathways, and prognostic significance in liver disease.
Explore frontiers →
Viral Hepatitis E Zoonotic Transmission
Analysis of hepatitis E virus animal reservoirs, cross-species transmission, and human infection prevention strategies.
Explore frontiers →
Hepatic Fibrosis Immune Tolerance Mechanisms
Examination of regulatory T-cell expansion, anti-inflammatory cytokines, and immune exhaustion in progressive fibrosis.
Explore frontiers →
Cholangiocarcinoma Patient-Derived Xenografts
Development and characterization of primary bile duct cancer models for drug screening and biomarker discovery.
Explore frontiers →
Liver Regeneration Epigenetic Modifications
Investigation of histone modifications, DNA methylation patterns, and chromatin remodeling during hepatic recovery.
Explore frontiers →
Hepatic Stellate Cell Quiescence Maintenance
Research on molecular mechanisms preserving hepatic stellate cell dormancy and prevention of fibrogenic activation.
Explore frontiers →
Drug-Induced Liver Injury Idiosyncratic Reactions
Investigation of genetic polymorphisms, immune sensitization, and reactive metabolite mechanisms in unpredictable drug hepatotoxicity.
Explore frontiers →
Hepatocellular Carcinoma Liquid Biopsy Biomarkers
Development of circulating tumor DNA, microRNA, and protein markers for non-invasive HCC detection and monitoring.
Explore frontiers →
Liver Cirrhosis Portal Collateral Angiogenesis
Study of neovascular formation and endothelial dysfunction in portosystemic shunt development and hemodynamic changes.
Explore frontiers →
Hepatic Mitochondrial Quality Control Autophagy
Analysis of mitophagy selectivity, PINK1-PARKIN pathway activation, and mitochondrial fission-fusion dynamics.
Explore frontiers →
Metabolic-Associated Fatty Liver Disease Insulin Resistance
Investigation of hepatic insulin signaling impairment, gluconeogenic dysregulation, and molecular mechanisms of metabolic dysfunction.
Explore frontiers →
Cholestatic Liver Disease Immunoglobulin A Nephropathy
Characterization of systemic immune complexes and glomerular IgA deposition in primary sclerosing cholangitis patients.
Explore frontiers →
Hepatocellular Carcinoma Immunosuppressive Microenvironment
Examination of myeloid-derived suppressor cells, regulatory T-cells, and immunosuppressive cytokine networks in HCC.
Explore frontiers →
Liver Fibrosis Mechanical Stiffness Sensing
Investigation of mechanotransduction pathways, YAP-TAZ signaling, and ECM stiffness-induced fibrogenic responses.
Explore frontiers →
Viral Hepatitis D Antigen Processing
Research on hepatitis D large and small antigen expression, processing, and interactions with hepatitis B surface antigen.
Explore frontiers →
Hepatic Lipid Droplet Proteolysis Turnover
Study of adipose triglyceride lipase, comparative gene identification-58, and protein lipase maturation factor 1 regulation.
Explore frontiers →
Primary Sclerosing Cholangitis Fibroblast Heterogeneity
Analysis of portal and periductal myofibroblast populations and their distinct transcriptomic profiles in PSC pathogenesis.
Explore frontiers →
Hepatocellular Carcinoma Radiotherapy Combination Therapy
Investigation of radiation-induced immunogenic cell death mechanisms and optimal timing of immunotherapy co-administration.
Explore frontiers →
Liver Acute Kidney Injury Cross-Organ Signaling
Research on hepatorenal crosstalk through extracellular vesicles and circulating factors in end-stage liver disease.
Explore frontiers →
Hepatitis B Immune Escape Glycan Shield
Study of viral envelope glycosylation patterns, antibody evasion mechanisms, and vaccine-escape mutant selection.
Explore frontiers →
Hepatic Macrophage Heterogeneity Functional Subsets
Characterization of tissue-resident macrophage, monocyte-derived macrophage, and infiltrating macrophage phenotypes in liver disease.
Explore frontiers →
Cholangiocarcinoma Lymph Node Metastasis Mechanisms
Investigation of lymphatic vessel invasion, lymph node-tropic chemokine expression, and immune cell recruitment in metastasis.
Explore frontiers →
Fatty Liver Disease De Novo Lipogenesis Control
Analysis of sterol regulatory element-binding protein, acetyl-CoA carboxylase, and fatty acid synthase dysregulation.
Explore frontiers →
Liver Transplant Tolerance Operational Tolerance
Research on spontaneous immunological tolerance in liver recipients and mechanisms enabling stable allograft without immunosuppression.
Explore frontiers →
Hepatocellular Carcinoma Senescence-Like Phenotype
Study of therapy-induced cellular senescence, senescence-associated secretory phenotype, and stromal interactions in HCC.
Explore frontiers →
Viral Hepatitis C microRNA Host Interactions
Examination of viral and cellular microRNA networks regulating viral replication, translation, and immune evasion.
Explore frontiers →
Liver Cirrhosis Bacterial Translocation Pathways
Investigation of altered intestinal microbiota composition, barrier function, and pathogen-associated molecular pattern recognition.
Explore frontiers →
Hepatic Progenitor Cell Niche Microenvironment
Characterization of cellular and acellular components surrounding liver progenitor cells and their developmental signals.
Explore frontiers →
Cholestasis-Associated Pruritogen Identification
Research on endogenous and exogenous itch-inducing substances, sensory neuron activation, and therapeutic antagonists.
Explore frontiers →
Hepatic Lipid Peroxidation and Ferroptosis Regulation
Investigation of iron-dependent cell death pathways in hepatocytes and their role in liver disease progression and potential therapeutic targeting.
Explore frontiers →
Liver Microarchitecture Zonation Metabolic Heterogeneity
Study of spatial metabolic differences across hepatic zones and their implications for disease pathogenesis and drug responses.
Explore frontiers →
Hepatic Immune Checkpoint Blockade Efficacy Enhancement
Research on optimizing PD-1/PD-L1 and CTLA-4 inhibitor responses through combination strategies in hepatocellular carcinoma.
Explore frontiers →
Liver-Gut Barrier Dysfunction and Bacterial Translocation
Examination of tight junction disruption mechanisms enabling pathogenic bacterial passage and subsequent hepatic inflammation.
Explore frontiers →
Hepatic Fibroblast Growth Factor Signaling Pathways
Analysis of FGF19/21 and FGF receptor interactions in metabolic homeostasis and fibrosis regression.
Explore frontiers →
Cholangiocyte Autophagy and Cystic Fibrosis Cholangiopathy
Investigation of impaired autophagy in CF-related liver disease and potential restoration strategies.
Explore frontiers →
Hepatocellular Carcinoma Somatic Mutation Landscape Evolution
Characterization of clonal heterogeneity and mutational burden patterns predicting treatment response and prognosis.
Explore frontiers →
Liver Proteasomal Dysfunction and Protein Aggregation
Study of impaired proteolytic clearance mechanisms in neurological hepatic disease and acute liver failure.
Explore frontiers →
Hepatic MicroRNA Dysregulation in Metabolic Disease
Analysis of miRNA-mediated post-transcriptional control of lipid metabolism and insulin signaling in fatty liver.
Explore frontiers →
Cirrhotic Portal Vein Thrombosis Hypercoagulability Mechanisms
Investigation of tissue factor pathway activation and platelet dysfunction contributing to thrombotic complications.
Explore frontiers →
Hepatic Dendritic Cell Maturation and Tolerance Induction
Research on how liver-resident dendritic cells maintain immune tolerance and implications for autoimmune hepatitis.
Explore frontiers →
Hepatitis B Core Antigen Immunogenicity and Vaccination
Development of novel vaccine strategies targeting HBcAg-specific T cell responses for functional HBV cure.
Explore frontiers →
Liver Fibrosis Elastography and Shear Wave Quantification
Validation and optimization of ultrasound and MRI elastography techniques for precise fibrosis staging and progression monitoring.
Explore frontiers →
Hepatic Acetyl-CoA Metabolism and Histone Acetylation
Exploration of epigenetic regulation through acetyl-CoA availability and histone modification patterns in metabolic liver disease.
Explore frontiers →
Primary Biliary Cholangitis Mitochondrial Autoimmunity
Characterization of molecular mimicry mechanisms triggering anti-mitochondrial antibody responses and cholangiocyte destruction.
Explore frontiers →
Hepatic Adenosine Signaling and Fibrosis Modulation
Investigation of A2A and A2B receptor pathways in immune regulation and stellate cell activation during liver fibrosis.
Explore frontiers →
Hepatocellular Carcinoma Single-Cell RNA Sequencing Analysis
High-resolution transcriptomic profiling of tumor and immune cell heterogeneity to identify immunotherapy-resistant subpopulations.
Explore frontiers →
Hepatic Kupffer Cell Metabolic Reprogramming and Activation
Study of metabolic switching between glycolysis and oxidative phosphorylation in macrophage-mediated inflammation.
Explore frontiers →
Drug-Induced Liver Injury Bioactivation and Protein Adducts
Analysis of xenobiotic metabolite-protein conjugate formation and immune tolerance breaking in idiosyncratic hepatotoxicity.
Explore frontiers →
Hepatic Endocannabinoid System and Metabolic Regulation
Examination of CB1 and CB2 receptor signaling in steatosis development and fibrosis progression.
Explore frontiers →
Cholangiocarcinoma Perineural Invasion and Metastatic Capacity
Investigation of nerve fiber interactions enabling tumor cell dissemination and neural-mediated immune evasion.
Explore frontiers →
Liver Regeneration Epigenetic Memory and Metabolic Recovery
Study of DNA methylation and chromatin remodeling patterns governing hepatocyte proliferation and functional restoration.
Explore frontiers →
Hepatic Starvation Response and Metabolic Switching Control
Analysis of AMPK and mTOR pathway coordination in nutrient sensing and ketogenesis regulation.
Explore frontiers →
Hemochromatosis Hepcidin Regulation and Iron Toxicity
Investigation of ferroportin-mediated iron efflux dysfunction and reactive oxygen species generation in hereditary hemochromatosis.
Explore frontiers →
Hepatitis G Virus Persistence and Viral Evolution Dynamics
Characterization of GBV-C quasispecies complexity and mechanisms enabling chronic infection despite immune responses.
Explore frontiers →
Liver Cancer Stem Cell Self-Renewal and Differentiation
Investigation of Wnt/β-catenin and Notch pathway signaling maintaining hepatocellular carcinoma-initiating cell properties.
Explore frontiers →
Hepatic Tumorigenesis Inflammatory Pathway Activation Crosstalk
Study of NF-κB, STAT3, and IL-6 signaling interplay driving chronic inflammation-to-cancer progression.
Explore frontiers →
Cirrhosis Renal Vasoconstriction and Cardiorenal Syndrome Pathogenesis
Examination of vasopressin and renin-angiotensin-aldosterone system dysregulation in hepatorenal syndrome development.
Explore frontiers →
Nonalcoholic Fatty Liver Disease Lipophagic Autophagy Signaling
Analysis of selective lipid autophagy mechanisms and their regulation by nutrient sensing pathways.
Explore frontiers →
Hepatic Natural Killer Cell Exhaustion and Functional Recovery
Investigation of NK cell checkpoint expression and strategies to restore cytotoxic function in chronic viral hepatitis.
Explore frontiers →
Hepatocellular Carcinoma CAR-T Cell Therapy Development Strategy
Design and optimization of chimeric antigen receptor T cells targeting HCC-specific antigens with enhanced tumor infiltration.
Explore frontiers →
Primary Sclerosing Cholangitis Duct Epithelial Cell Cross-Talk
Study of cholangiocyte-immune cell interactions and bacterial lipopolysaccharide sensing in progressive biliary inflammation.
Explore frontiers →
Hepatic Cytochrome P450 Epigenetic Silencing and Dysregulation
Analysis of DNA methylation and histone modification patterns controlling drug-metabolizing enzyme expression in liver disease.
Explore frontiers →
Alcoholic Liver Disease Oxidative Stress and Lipid Peroxidation
Investigation of ethanol-induced free radical generation and antioxidant enzyme depletion mechanisms.
Explore frontiers →
Hepatic Ischemia-Reperfusion Injury Prevention Strategies
Development of pharmacological and conditioning approaches to reduce post-transplantation graft dysfunction and inflammation.
Explore frontiers →
Cholestatic Bile Acid Accumulation and TGR5 Signaling Therapy
Exploration of G-protein coupled receptor activation in reducing bile acid toxicity and hepatic inflammation.
Explore frontiers →
Hepatitis C Viral Protein-Induced Endoplasmic Reticulum Stress
Analysis of HCV NS proteins triggering unfolded protein response pathways and hepatocyte apoptosis mechanisms.
Explore frontiers →
Liver Graft Tolerance and Regulatory T Cell Induction
Investigation of mechanisms enabling operational tolerance in liver transplantation and Foxp3+ Treg expansion strategies.
Explore frontiers →
Hepatocellular Carcinoma Angiogenic Switch and Neovascularization
Study of VEGF, FGF, and Ang/Tie signaling in tumor blood vessel formation and anti-angiogenic therapy resistance.
Explore frontiers →
Intrahepatic Cholestasis Pregnancy FXR Signaling and Progesterone
Analysis of farnesoid X receptor dysfunction and bile salt export pump downregulation under pregnancy hormone effects.
Explore frontiers →
Liver Cirrhosis Bacterial Lipopolysaccharide and TLR4 Activation
Investigation of pattern recognition receptor signaling in bacterial translocation and systemic inflammatory response syndrome.
Explore frontiers →
Hepatic Progenitor Cell Niche Microenvironment and Differentiation
Study of extracellular matrix composition and growth factor availability controlling ductular reaction and cell fate.
Explore frontiers →
Cholangiocarcinoma Immunosuppressive Microenvironment and Tregs
Characterization of IL-10 and TGF-β signaling pathways promoting regulatory T cell infiltration and tumor tolerance.
Explore frontiers →
Viral Hepatitis B Functional Cure cccDNA Eradication Mechanisms
Investigation of covalently closed circular DNA degradation pathways and genome editing approaches for HBV elimination.
Explore frontiers →
Hepatic Lipid Droplet Protein Coating and Lipolysis Regulation
Analysis of PLIN, CGI-58, and ATGL interactions controlling lipid mobilization and energy metabolism.
Explore frontiers →
Nonalcoholic Fatty Liver Disease Fibrosis Progression Prediction Models
Development of machine learning algorithms integrating genetic, metabolic, and imaging biomarkers for personalized risk stratification.
Explore frontiers →
Hepatocyte Mitochondrial DNA Copy Number and Heteroplasmy Dynamics
Investigation of mtDNA burden changes during liver disease progression and their functional metabolic consequences.
Explore frontiers →
Liver Fibrosis Hepatic Stellate Cell Quiescence Maintenance Mechanism
Study of mechanisms preserving quiescent state in HSCs and factors triggering re-activation during fibrosis reversal.
Explore frontiers →
Hepatitis C Viral Quasispecies Complexity and Immune Escape
Characterization of HCV sequence heterogeneity enabling adaptive immune evasion and chronic persistent infection.
Explore frontiers →
Liver Regeneration Epigenetic Silencing and Dedifferentiation Control
Analysis of chromatin accessibility changes and histone mark dynamics during hepatocyte proliferation and maturation.
Explore frontiers →
Hepatocellular Carcinoma Epigenetic Reprogramming
Investigation of DNA methylation, histone modifications, and chromatin remodeling patterns that drive HCC development and progression.
Explore frontiers →
Liver Fibrosis Extracellular Matrix Degradation
Study of matrix metalloproteinase regulation and tissue inhibitor mechanisms for therapeutic ECM remodeling in advanced fibrosis.
Explore frontiers →
Non-Alcoholic Fatty Liver Disease Endoplasmic Reticulum Stress
Examination of unfolded protein response activation and ER stress-induced lipotoxicity in NAFLD pathogenesis.
Explore frontiers →
Hepatitis B Core Antigen Immune Tolerance
Analysis of HBcAg-specific T-cell exhaustion and regulatory T-cell mechanisms in chronic hepatitis B infection.
Explore frontiers →
Liver Cancer Stem Cell Niche Biology
Investigation of hypoxic and perivascular microenvironments supporting hepatic cancer stem cell maintenance and self-renewal.
Explore frontiers →
Cholestatic Liver Disease Farnesoid X Receptor Signaling
Research on FXR agonist therapeutic mechanisms and nuclear receptor cross-talk in cholestatic disease treatment.
Explore frontiers →
Hepatic Inflammation Resolution Lipid Mediators
Study of specialized pro-resolving mediators including lipoxins, resolvins, and protectins in hepatic inflammation termination.
Explore frontiers →
Primary Biliary Cholangitis Autoantigen Discovery
Identification of novel mitochondrial and non-mitochondrial autoantigens driving PBC-specific B and T cell responses.
Explore frontiers →
Liver Fibrosis Artificial Intelligence Staging
Development of machine learning and deep learning algorithms for accurate fibrosis stage prediction from imaging and serological data.
Explore frontiers →
Hepatocellular Carcinoma Immunotherapy Checkpoint Combination
Clinical and mechanistic investigation of synergistic effects combining PD-1, CTLA-4, and LAG-3 checkpoint inhibition in HCC.
Explore frontiers →
Hepatitis C Virus Lipid Droplet Interaction
Examination of HCV replication complex association with lipid droplets and therapeutic targeting of viral lipid biogenesis.
Explore frontiers →
Drug-Induced Liver Injury Genetic Polymorphisms
Investigation of HLA alleles, drug metabolism gene variants, and immune response polymorphisms predicting DILI susceptibility.
Explore frontiers →
Portal Hypertension Endothelial Dysfunction Mechanics
Analysis of endothelial nitric oxide synthase uncoupling and eNOS-derived superoxide production in portal hypertensive sinusoids.
Explore frontiers →
Cholangiocarcinoma PD-L1 Expression Immunogenicity
Investigation of PD-L1 expression patterns, tumor mutational burden, and neoantigen landscape in cholangiocarcinoma subtypes.
Explore frontiers →
Hepatic Senescence and Aging-Related Liver Disease
Study of cellular senescence markers, senescent cell accumulation, and senotherapy approaches in aged liver disease.
Explore frontiers →
Metabolic Dysfunction-Associated Steatohepatitis Ferroptosis
Investigation of iron metabolism dysregulation and ferroptotic cell death pathways in MASH progression.
Explore frontiers →
Hepatic Immune Tolerance Regulatory T Cell Metabolism
Examination of Foxp3+ regulatory T cell metabolic adaptations and suppressive mechanisms in liver-specific immune tolerance.
Explore frontiers →
Hepatocellular Carcinoma Microbiota-Driven Immunotherapy
Study of commensal bacteria composition effects on anti-tumor immune response and immunotherapy efficacy in HCC.
Explore frontiers →
Acetaminophen-Induced Liver Injury Mechanistic Biomarkers
Investigation of early phase protein biomarkers, mitochondrial dysfunction markers, and acetyl-cysteine intervention mechanisms in APAP toxicity.
Explore frontiers →
Liver Sinusoidal Endothelial Cell Capillarization Prevention
Study of LSEC fenestration preservation mechanisms and anti-capillarization strategies to reverse cirrhotic endothelial dysfunction.
Explore frontiers →
Hepatitis Delta Virus Small Antigen Function
Research on hepatitis D small delta antigen protein interactions, subcellular localization, and pathogenic mechanisms.
Explore frontiers →
Cirrhosis-Related Adrenal Insufficiency Pathophysiology
Investigation of hypothalamic-pituitary-adrenal axis dysfunction and cortisol metabolism alterations in decompensated cirrhosis.
Explore frontiers →
Liver Organoid Platform Drug Toxicity Testing
Development of complex 3D hepatic organoid models incorporating multiple cell types for high-throughput drug safety evaluation.
Explore frontiers →
Hepatic Fibrosis Transcriptome-Wide Association Studies
Genome-wide expression QTL mapping and TWAS analysis identifying disease-associated liver gene expression signatures.
Explore frontiers →
Autoimmune Hepatitis Regulatory T Cell Dysfunction
Study of defective FoxP3+ Treg development and suppressive function in autoimmune hepatitis pathogenesis.
Explore frontiers →
Hepatocellular Carcinoma Exosomal microRNA Signatures
Investigation of circulating exosomal microRNA biomarkers for HCC diagnosis, prognosis, and treatment response monitoring.
Explore frontiers →
Bile Acid Farnesoid X Receptor G-Protein Coupled Receptor
Study of dual FXR and TGR5 signaling pathway activation by bile acids in metabolic and immune regulation.
Explore frontiers →
Hepatic Apoptosis Resistance Survival Pathway Addiction
Examination of anti-apoptotic protein over-expression and survival kinase dependencies in hepatocyte transformation.
Explore frontiers →
Liver Fibrosis Single-Cell RNA Sequencing Landscape
High-resolution cell type identification, state transitions, and cell-cell communication mapping in fibrosis progression using scRNAseq.
Explore frontiers →
Hepatitis E Virus Quasi-Species Evolution
Investigation of HEV genetic heterogeneity, adaptive mutations, and immune escape mechanisms in chronic infection.
Explore frontiers →
Hepatic Stellate Cell Lipid Droplet Accumulation
Study of vitamin A ester storage and metabolic remodeling during HSC activation and fibrogenic differentiation.
Explore frontiers →
Cholestasis-Induced Renal Dysfunction Pathophysiology
Investigation of bile acid-mediated tubular injury, renin-angiotensin activation, and hepato-renal cross-talk in cholestasis.
Explore frontiers →
Hepatocellular Carcinoma Patient-Derived Xenograft Models
Development and characterization of immunocompetent PDX models preserving tumor heterogeneity for personalized therapy testing.
Explore frontiers →
Liver Fibrosis Extracellular Matrix Imaging Biomarkers
Development of advanced imaging techniques including elastography and molecular imaging for non-invasive ECM assessment.
Explore frontiers →
Portal Vein Thrombosis Prothrombotic Factor Analysis
Investigation of JAK2, CALR, MPL mutations, myeloproliferative disorders, and acquired thrombophilia in PVT development.
Explore frontiers →
Hepatic Progenitor Cell Transdifferentiation Mechanisms
Study of bipotent liver progenitor plasticity, cholangiocyte versus hepatocyte lineage specification, and lineage reprogramming factors.
Explore frontiers →
Non-Alcoholic Fatty Liver Disease Inflammasome Activation
Investigation of NLRP3 inflammasome priming, activation signals, and IL-1β-mediated inflammation in NAFLD progression.
Explore frontiers →
Cirrhotic Cardiomyopathy Molecular Mechanisms
Study of portal hypertension-induced cardiac dysfunction, nitric oxide resistance, and systolic-diastolic impairment mechanisms.
Explore frontiers →
Hepatocellular Carcinoma Natural Killer Cell Exhaustion
Investigation of NK cell receptor expression changes, cytotoxic granule depletion, and tumor-derived suppressive mediators in HCC.
Explore frontiers →
Liver Fibrosis Wnt-Beta-Catenin Signaling Regulation
Study of canonical Wnt pathway activation in HSCs, TCF/LEF target gene expression, and Wnt inhibitor therapeutic strategies.
Explore frontiers →
Hepatic Ischemia-Reperfusion Injury Mitochondrial Dynamics
Investigation of mitochondrial fission-fusion balance, cristae remodeling, and OPA1-mediated protection during hepatic IRI.
Explore frontiers →
Primary Sclerosing Cholangitis Microbiota Dysbiosis
Analysis of gut microbiota composition alterations, bacterial translocation, and microbe-derived metabolite changes in PSC.
Explore frontiers →
Hepatocellular Carcinoma Fibroblast Growth Factor Signaling
Study of FGF1-4 ligands, FGFR isoform expression, and autocrine-paracrine FGF pathway activation in HCC proliferation.
Explore frontiers →
Liver Regeneration Epigenetic Memory Imprinting
Investigation of histone modification dynamics, DNA methylation remodeling, and epigenetic priming during hepatic mass restoration.
Explore frontiers →
Metabolic-Associated Fatty Liver Disease Lipid Mediator Profiling
Lipidomic analysis of polyunsaturated fatty acid metabolites, prostaglandins, and cannabinoid-like lipids in MAFLD pathology.
Explore frontiers →
Hepatitis B Capsid Assembly Inhibitor Mechanisms
Study of core protein assembly inhibitors targeting HBV particle formation and their effect on covalently closed circular DNA.
Explore frontiers →
Cholangiocarcinoma Perineural Invasion Promotion
Investigation of neural-derived neurotrophic factors, axon-cancer cell interactions, and pain-associated neural remodeling in ICC progression.
Explore frontiers →
Hepatic Encephalopathy Manganese Accumulation Mechanism
Study of manganese transporter dysregulation, brain accumulation pathways, and T1 weighted MRI changes in hepatic encephalopathy.
Explore frontiers →
Hepatocellular Carcinoma Proteogenomic Biomarker Integration
Combined genomic, transcriptomic, and proteomic analysis to identify multi-omics HCC subtypes and therapeutic vulnerabilities.
Explore frontiers →
Hepatic Kupffer Cell Ferroptosis Immunoregulation
This research investigates how ferroptosis in hepatic Kupffer cells regulates liver inflammation and immune tolerance, with implications for treating fibrosis, viral hepatitis, and hepatocellular carcinoma through modulation of iron-dependent cell death pathways.
Explore frontiers →